Pre-clinical models of infectious diseases task order B07
Ended Awarded Last action
- Contract number
- 75N93020F00001
- Awardee
-
Lovelace Biomedical And Environmental Research Institute, Inc. UEI N1UBCLRAPNG6 Part of Lovelace Biomedical Research Institute
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $929,570
Award facts
- Contract value 12% obligated
-
- $929,569.62 Current, with exercised options
- $7,956,047.62 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$79,372 | |
| Other Administrative Action | $0 | |
| Change Order | $340,289 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $668,653 |
About this award
This is a task order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization. The task order, titled "PRE-CLINICAL MODELS OF INFECTIOUS DISEASES TASK ORDER B07", is part of NIAID's Preclinical Models of Infectious Diseases contract vehicle, which provides preclinical research services to support the development of treatments and cures for infectious diseases. This $7,956,047.62 cost-plus-fixed-fee task order has a performance period running through July 13, 2024. The contract does not have a set-aside designation. As a subsidiary of Lovelace Biomedical Research Institute, LBERI leverages over 70 years of expertise in areas like inhalation toxicology, infectious disease modeling, and medical countermeasure testing to support federal agencies such as NIAID, the Biomedical Advanced Research and Development Authority (BARDA), and the National Center for Advancing Translational Sciences (NCATS).
Quick answers
Who was awarded contract 75N93020F00001?
75N93020F00001 was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2020.
How much is contract 75N93020F00001 worth?
The government has obligated $929,570 on 75N93020F00001. Its potential value, with all options, is $7,956,048.
Is contract 75N93020F00001 an order under another contract?
Yes. 75N93020F00001 is a delivery order under HHSN272201700024I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93020F00001 competed?
The extent of competition for 75N93020F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award